chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joint pains- hands and feet noted 6/11/07. Workup showed (+) ANA of 1:160. Patient read article from "National Vaccine Information Center" and would like this to be reported as a possible adverse event following Gardasil to VAERS
Approximately 6 hours after vaccine, developed severe left lower jaw pain; this persisted for 6 hours Approximately 12 hours after vaccine, I had myalgias, shaking chills, nausea, and vomited 3 times over a period of 3 hours
Sudden severe tinnitus in left ear.  Sudden severe headaches in rear, left side, near the base of the skull.
This spontaneous report as received from a physician refers to a 9 week old patient of unknown gender. Pertinent medical history, concurrent conditions and concomitant medications were not reported. On 22-MAR-2016 the patient was vaccinated with PEDVAXHIB, 0.5 ml (lot # L038502 expiry date: 16-AUG-2018), intramuscular in the left leg. On 25-MAR-2016, the patient was inadvertently vaccinated with 0.5 ml of PEDVAXHIB again in the same left leg. The second administration was also from the same lot/ expiration date as first however a different vial. The patient did not experience any adverse event. Additional information has been requested.
Fever, chills, nausea the morning After vaccine. Took out the trash and had a cardiac arrest and fell. 911 called went to hospital 3 1/2 days no change. 2 Dr.s said no improvement brain dead. Had a living will disconnected after 48 hrs. Disconnected at 7:00 pm died 8:17 pm. 2/7/21
Information has been received from a physician concerning a teenage female who received her first and second doses of Gardasil in the buttocks. Subsequently the patient experienced pain at the site for a unspecified duration. Subsequently, the patient recovered from pain. Unspecified medical attention was sought. Additional information has been requested.
Received quadrivalent influenza vaccine mid-October 2015 in upper right arm. Started noticing itching and redness in stick area. Wheels/welts appeared, in addition to redness, on or about November 2, 2015.
Large red area measured 2" by 4" at site of injection hot with hard lump, next day became 2 1/2 by 4 1/2" redder and hotter. Next day grew to 3" by 5". Used ice pack Benadryl and cortisone cream starting on the  8th. It is now the 13th of May and still have the show of redness about the size of 3 x 5. Itched and stung as well as hot. No fever no respiratory problems. Druggist said I should report.
dysmenorrhea (Severe-Grade3); menorragie (severe-grade 3); stay in bed all day1 after the 2nd dose; Nausea (moderate); fever (max 100F); body aches and chills (mild, both).; body aches and chills (mild, both).; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 47-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EW0173) via an unspecified route of administration in right arm on 03May2021 at single dose for covid-19 immunization. Medical history included Unilateral post-oophorectomy, history of endometriosis. Patient was allergic to dextromethorphan, cat and dust. Concomitant medication included iron, ergocalciferol (VIT D), ascorbic acid (VIT C), zinc, elderberry (sambucus nigra) and probiotics. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient previously took dextromethorphan and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) for covid-19 immunisation. On 04May2021, around twenty hours post second dose the patient experienced symptoms which started and intensified to the point of incapacitation that stay in bed all day one after the second dose, moderate nausea, severe-grade3 dysmenorrhea, severe-grade 3 menorrhagia, fever (max 100F), mild body aches and mild chills. Dysmenorrhea and menorrhagia stopped on day two post second dose. The menstrual symptoms were unusual and occurred for the first time. In addition, mostly menorrhagia occurred again at the next period that started two days ago. No treatment was given for the events. On 17Mar2021, the patient underwent lab tests and procedures which included polymerase chain reaction: negative. The outcome of event was recovered on an unspecified date in May2021 date.
feel terrible; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Shingrix and Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Shingrix and Influenza vaccine Quadrivalent unspecified season, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was unknown.   It was unknown if the reporter considered the feeling bad to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix shot and a flu shot at the same time and feel terrible.
SLIGHT HEADACHE; This spontaneous report received from a patient concerned a 67 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. On MAR-2021, the subject experienced slight headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of slight headache was not reported. This report was non-serious.
3rd dose for an immunocompromised patient administered as a booster shot (half of a dose); 3rd dose for an immunocompromised patient administered out of schedule, approximately 4 to 6; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (3rd dose for an immunocompromised patient administered as a booster shot (half of a dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose for an immunocompromised patient administered out of schedule, approximately 4 to 6) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0000000) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (3rd dose for an immunocompromised patient administered as a booster shot (half of a dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose for an immunocompromised patient administered out of schedule, approximately 4 to 6). At the time of the report, ACCIDENTAL UNDERDOSE (3rd dose for an immunocompromised patient administered as a booster shot (half of a dose)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3rd dose for an immunocompromised patient administered out of schedule, approximately 4 to 6) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was reported.
This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On unknown date, the patient was vaccinated with the improperly stored dose of PROQUAD lot #: L024125, expiration date on 30-DEC-2016 (route, dose number and anatomical location were not provided). No adverse events were reported. Administered doses of vaccines experienced the temperature excursion of 22.1 degrees Celsius for 16 hours. Data logger was involved. There was no previous excursions reported. This is one of two reports received from the same source. Additional information has been requested.
that night at 4 am i got really cold and had flu like symptoms  which i understand was normal.  lasted about 36 hours.  my arm was sore from the vaccine but not bad.  don't know when but the muscle pain began to get worse and spread to my left shoulder and then to my left arm pit.  the pain was really bad and if i moved my arm wrong it could make me cry.   it is now over three weeks and has not changed.  my primary care doctor told me to take tylenol and use ice packs which did not help at all.
diarrhea; diarrhea; little nauseous; aching in her joints; no to little soreness in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (no to little soreness in her left arm), the second episode of DIARRHOEA (diarrhea), the first episode of DIARRHOEA (diarrhea), NAUSEA (little nauseous) and ARTHRALGIA (aching in her joints) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included Heart disorder.    On 12-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (no to little soreness in her left arm). On 15-Apr-2021, the patient experienced the first episode of DIARRHOEA (diarrhea), NAUSEA (little nauseous) and ARTHRALGIA (aching in her joints). On 20-Apr-2021, the patient experienced the second episode of DIARRHOEA (diarrhea). At the time of the report, PAIN IN EXTREMITY (no to little soreness in her left arm) had resolved, last episode of DIARRHOEA (diarrhea) outcome was unknown and NAUSEA (little nauseous) and ARTHRALGIA (aching in her joints) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medicine. Treatment medication not provided.
Booster shot-pain on left side where he got the shot from head to toe/pain from the booster is more severe and lasted a lot longer; Booster shot- headache; Booster shot-severe fatigue; Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Nov2021 (Lot number: FH8030) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose no: 1, Lot number: FN9166), administration date: 16Mar2021, when the patient was 54 years old, for COVID-19 immunization; Bnt162b2 (Dose no: 2, Lot number: FN6207), administration date: 06Apr2021, when the patient was 54 years old, for COVID-19 immunization, reaction(s): "Stated that two weeks prior to a holiday that he had the same symptoms as he had when he tested positive for Covid", "Stated that two weeks prior to a holiday that he had the same symptoms as he had when he tested positive for Covid", "Second shot- sore left arm", "Second shot: chest congestion", "Second shot: runny nose", "Second shot: coughing". The following information was reported: IMMUNISATION (non-serious) with onset 17Nov2021, outcome "unknown", described as "Booster"; PAIN (non-serious) with onset 26Nov2021, outcome "recovering", described as "Booster shot-pain on left side where he got the shot from head to toe/pain from the booster is more severe and lasted a lot longer"; FATIGUE (non-serious) with onset 19Nov2021, outcome "recovering", described as "Booster shot-severe fatigue"; HEADACHE (non-serious) with onset 26Nov2021, outcome "recovering", described as "Booster shot- headache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache.  Additional information: Reporter stated that the pain from the booster is more severe and lasted a lot longer.   Follow-Up (03Dec2021): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
This is a prospective pregnancy case. This 39-year-old female subject was enrolled in an open label study. The subject received FLUARIX QIV (intramuscular) .5 ml on 20th October 015. The subject received FLUARIX at week 8 of the pregnancy and during the first trimester of pregnancy. On 20th October 2015, 9 hrs after receiving FLUARIX, the subject developed vaginal bleeding (Non-serious). Additional event(s) including vaccine exposure during pregnancy. The outcome of vaginal bleeding was not recovered/not resolved. The outcome(s) of the additional event(s) included vaccine exposure during pregnancy (unknown). The pregnancy was ongoing. The investigator considered the vaginal bleeding to be possibly related to FLUARIX. Additional details were provided as follows: The patient received FLUARIX quadrivalent (batch number 33FF2, expiry date: 30th June 2016). The patient experienced vaginal bleeding which was described as light to moderate. At the time of reporting, the patient was visiting the emergency room because of the bleeding.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment information was provided.   This case was linked to (Patient Link).
Client came by clinic to update our medical records that she received pnuemonia vaccine in 2004.  Told nurse that she is in therapy for left shoulder pain that began 1 week after receiving flu shot in Dec 07. Is being followed by physician in clinic as well as orthopedic physician.  Has had flu vaccines from another provider in previous years.
24 hours of fever, 101 degrees plus.  Associated chills, fatigue, and loss of appetite.  Patient had previously presumed Covid in March 2020, not tested at the time,  but positive antibody test in June 2020, and positive antibody tests subsequently from August 2020 through February 2021 as part of a research study.
About 30 minutes after the vaccine I got a strange taste in my mouth which lasted about 30 minutes.   Both of my children 24/19 got their first Pfizer vaccine on 3/19/2021 and told me the same thing happened to them too.
Pt had swelling of face, tongue, ear 2 days after shot. BENADRYL taken per patient.
Administered to Newborn; Vaccine administered at inappropriate site; Initial Report Received on 15-Dec-2020  A pharmacist reported that a newborn female patient (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization.  No medical history or known drug allergies were reported.   No concomitant medications were reported.  On 09-Dec-2020, on the day of birth, the patient received a dose of HEPLISAV-B (Lot # 933839, expiration date 28-Feb-2021 and NDC # not reported) to the left thigh.  At the time of report, no adverse reactions had been reported.  No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Headache,  chills, vomiting,  fatigue about 18 hours after vaccine
Pain in the left hip constant for the most part. Pain is moving around- not constantly in one particular place-   in the lower part of the body-mostly in joints- in knee,ankles and back-around waist line. Swollen lymph nods in both groins - left is very pronounced - about the size of an egg.Blood ( directed by gynochologist )test didn't show an infection and no problems gynochologicly.
Racing heart, palpitations, anxiety, depression, fatigue,  weight loss, nausea, diarrhea, crying,
First, about 8 hours after the vaccine I had flu symptoms; mostly just a gnarly fever and that ran 24 hours. Seven days of liquid diarrhea; I went to Care Physician. They didn't have an answer as to why it happened, but it did correct itself.  No treatment.
"I received the flu shot in my upper right arm on Oct 6th and I'm still have muscle pain around injection site more than a month later."
Sore arm; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.   On unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event Sore arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event sore arm was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
improperly stored vaccines administered to patients; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 02-SEP-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # T032149, expiration date 20-MAR-2022, (dose, route and frequency were not reported) for prophylaxis.   The reporter stated that the excursion occurred between 01-SEP-2021 and 09-SEP-2021; as the vaccines were stored in the freezer and got too warm and they did not realize that the freezer was "going in and out of range" (temperature of excursion and duration of excursion were not reported). Also, the reporter mentioned that the remaining vaccines were back in the recommended temperature range but she did not have information needed to evaluate at the reporting time.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA002915:Original Case : 2109USA002915
Information has been received from a mother for GARDASIL, a Pregnancy Registry product, concerning her 8 week old baby. On an unknown date in December 2011 the mother was vaccinated with the first dose of GARDASIL (lot number 0626AA) (dose, route and injection site were not reported). On 28-FEB-2012, the mother was vaccinated with the second dose of GARDASIL (lot number, dose, route and injection site were not reported). On 23-MAR-2012 the mother found she was pregnant and on 26-NOV-2012 she delivered the infant. The baby was born on 26-NOV-2012, and died on 25-JAN-2013. Toxicology tests are being run to see the cause of death. The action taken and causality of death was not provided. The mother's information was captured in MARRS # 1304USA006478 (Parent-Child Link). Additional information is not expected.
pt recv vax 28SEP95 & later the same day pt exp very sore axillary & breast, had devel swelling on arm @ the inj site;also had a fever of over 101;tx w/APAP;
Spinal infarct @ T 10-12, resulting in paraplegia.  Symptoms began 4 days after receiving vaccine. Leg numbness and flaccidity, loss of bowel and bladder function.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. Pertinent medical history and drug reaction/allergies were not reported. In February 2014, the patient was vaccinated with a first dose of GARDASIL (lot number, dose, and route were not reported). In June 2014, the patient was vaccinated with a second dose of GARDASIL (lot number, dose and route were not reported). No adverse effect reported. This is one of two (1407US008688) reports from the same source. Additional information has been requested.
pt recv vax & exp a vaccine failure & devel chickenpox;A total of 7 patients from a daycare ctr were reported;
Hives and swelling of left are that started about 3 hours after my shot and lasted for about 3 hours. I was at work so I had no access to any allergy meds